Clinical implications of pretreatment inflammatory biomarkers as independent prognostic indicators in prostate cancer-Reference-Cited by-同舟云学术

Clinical implications of pretreatment inflammatory biomarkers as independent prognostic indicators in prostate cancer

Published:2017-06-12 Issue:3 Volume:32 Page:e22277
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:J Clin Lab Anal

Author:

Sun Zhaohui¹^ORCID,Ju Ying²,Han Fuyan²,Sun Xiya³,Wang Fang¹

Affiliation:

1. Department of Clinical Laboratory; The Second Hospital of Shandong University; Jinan Shandong China

2. Department of Clinical Laboratory; Shandong Provincial Hospital Affiliated to Shandong University; Jinan Shandong China

3. School of Basic Medical Sciences of Lanzhou University; Lanzhou Gansu China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Reference31 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. Prostate cancer in East Asia: evolving trend over the last decade;Zhu;Asian J Androl,2015

3. Orphan nuclear receptor nurr1 as a potential novel marker for progression in human prostate cancer;Wang;Asian Pac J Cancer Prev,2013

4. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

5. Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients;Azab;Med Oncol,2013

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of the Predictive Value of De Ritis Ratio and Inflammatory Markers in Prostate Cancer Patients Suitable for Active Surveillance;Journal of Academic Research in Medicine;2024-07-31

2. The use of platelets as a clinical tool in oncology: opportunities and challenges;Cancer Letters;2024-06

3. Association between platelet‑to‑lymphocyte ratio and serum prostate specific antigen;Molecular and Clinical Oncology;2023-12-12

4. Association Between Platelet-to-lymphocyte ratio(PLR) And Serum Prostate Specific Antigen (PSA) Among U.S. Males;2023-08-25

5. Inflammation-related indicators have a potential to increase overall quality of the prostate cancer management: a narrative review;Translational Andrology and Urology;2023-05